High-risk localized prostate cancer: primary surgery and adjuvant therapy. Urol Oncol 2003;21: 219.Eila C, SkinnerL.Michael, Glode. (2003) High-risk localized prostate cancer: primary surgery and adjuvant therapy. Urologic Oncology: Seminars and Original Investigations 21 , 219-227 /...
Prostate cancer is a common type of cancer that affects men, and it occurs in the prostate gland which is a part of the male reproductive system. High-risk prostate cancer refers to aggressive and advanced forms of the disease that are more likely to spread to other parts of the body. Th...
Response:Our study provides evidence to suggest that delivering adjuvant as compared to early salvage radiation therapy can reduce the risk of death by decreasing death from prostate cancer in men found to have adverse pathology at surgery. MedicalResearch.com: What should readers take away from you...
1)intermediate or high risk prostate cancer中高危前列腺癌 2)BPH in high risk高危前列腺 1.Objective: To assess safety of transurethral plasma kinetic resection of prostate forBPH in high risk.目的探讨经尿道双极等离子治疗高危前列腺增生症(BPH)的安全性与可靠性。 英文短句/例句 1.Clinical analysis on...
High-risk prostate cancer (PCa) harbours a risk of local, regional and systemic relapse requiring the combination of a loco-regional treatment such as external beam radiotherapy for controlling the pelvic-confined disease, combined with an androgen deprivation therapy (ADT) to potentiate irradiation ...
Patients with high-risk prostate cancer treated with curative intent are at an increased risk of biochemical recurrence, metastatic progression and cancer-related death compared with patients treated for low-risk or intermediate-risk disease. Thus, these patients often need multimodal therapy to achieve...
High-risk prostate cancer is a heterogeneous disease that lacks clear consensus on its ideal management. Historically, non-surgical treatment was the preferred strategy, and several studies demonstrated improved survival among men with high-risk disease managed with the combination of radiotherapy and ...
Radiation therapy combined with androgen-deprivation therapy has become the standard-of-care treatment for patients with high-risk prostate cancer; however, superiority of this approach over other therapeutic options, such as surgery, has not been clearl
Imaging high-risk prostate cancer is predominantly conducted using radionuclide bone scan, CT, and MRI Multiparametric-MRI (mpMRI) and positron emission tomography (PET)–CT, using novel imaging techniques and radiopharmaceuticals, are currently being investigated and incorporated into clinical use ...
Overall survival benefit of androgen suppression in addition to dose-escalated external beam radiotherapy for high-risk prostate cancer: Nationwide real-wo... To evaluate the real-world added value of androgen deprivation therapy (ADT) in addition to external beam radiotherapy (EBRT) in men with ...